Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M38,985Revenue (TTM) $M2,131Net Margin (%)12.2Altman Z-Score13.9
Enterprise Value $M38,081EPS (TTM) $1.0Operating Margin %16.2Piotroski F-Score8
P/E(ttm)150Beneish M-Score-2.8Pre-tax Margin (%)12.7Higher ROA y-yY
Price/Book23.010-y EBITDA Growth Rate %--Quick Ratio3.3Cash flow > EarningsY
Price/Sales18.05-y EBITDA Growth Rate %--Current Ratio3.5Lower Leverage y-yY
Price/Free Cash Flow64.0y-y EBITDA Growth Rate %--ROA % (ttm)9.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)20.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M252ROIC % (ttm)41.9Gross Margin Increase y-yY

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

VRTX is held by these investors:



VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SMITH IAN FEVP, COO 2017-10-16Sell2,125$155.61-0.63view
Chodakewitz JeffreyEVP GMDA, CMO 2017-10-16Sell1,718$155.19-0.36view
Parini MichaelEVP, CL&AO 2017-10-12Sell2,125$152.931.11view
Chodakewitz JeffreyEVP GMDA, CMO 2017-10-02Sell3,437$151.641.97view
ALTSHULER DAVIDEVP, Global Research and CSO 2017-08-31Sell1,796$160-3.36view
Silva Paul MSVP & Corp Controller 2017-08-07Sell1,289$152.881.14view
Arbuckle Stuart AEVP\Chief Commercial Officer 2017-08-07Sell4,250$152.881.14view
SMITH IAN FEVP, CFO & COO 2017-08-07Sell4,250$155.39-0.49view
Arbuckle Stuart AEVP\Chief Commercial Officer 2017-08-03Sell4,250$155.72-0.7view
Parini MichaelEVP, CL&AO 2017-08-03Sell2,330$155.72-0.7view

Quarterly/Annual Reports about VRTX:

    News about VRTX:

    Articles On GuruFocus.com
    5 Health Care Companies in Gurus' Portfolios Oct 16 2017 
    Vanguard Sells Medtronic, Cigna in 2nd Quarter Aug 17 2017 
    Weekly CFO Sells Highlight Jul 30 2017 
    Vertex Energy, Inc. to Release Second Quarter 2017 Financial Results on August 8, 2017 Jul 25 2017 
    The Real Reason Why the Latest Vertex Pharmaceutical Data Is so Important Jul 20 2017 
    Spiros Segalas Gains 5 New Holdings in 2nd Quarter Jul 10 2017 
    Weekly CFO Sells Highlight Jun 08 2017 
    Eaton Vance Worldwide Health Sciences Fund 1st Quarter Investment Report May 02 2017 
    Galapagos NV Tests Cystic Fibrosis Treatment on First Patient Feb 03 2017 
    Galapagos NV Announces Results From Cystic Fibrosis Treatment Study Dec 27 2016 

    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}
    FEEDBACK